Orphan Technologies to be acquired by Retrophin for up to USD 517m 

Retrophin, a San Diego, California-based biopharmaceutical company, will acquire Orphan Technologies Limited, a Swiss clinical-stage biopharmaceutical company, for up to USD 517m.

Cooley acted as legal counsel to Retrophin. Barclays acted as financial advisor.

Hogan Lovells US acted as legal counsel to Orphan Technologies and Cantor Fitzgerald & Co. acted as financial advisor.

Orphan Technologies to be acquired by Retrophin for up to USD 517m 



Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram